ALPHATEC HOLDINGS, INC. (ATEC) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value -1.02×; Formula and calculation Operating income ÷ reported interest expense..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | -1.02× | Operating income ÷ reported interest expense. $-49.24M ÷ $48.46M ≈ -1.02× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | (m) | |
| Stock-based compensation | 77.58M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -49.24M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | 48.46M USD | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: Reported. Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $77.58M | $-49.24M | $48.46M | (m) | (m) | -1.02× | Reported |
| 2026-03-31 | (m) | (m) | $75.06M | $-60.42M | $49.80M | (m) | (m) | -1.21× | Reported |
| 2025-12-31 | (m) | (m) | $73.72M | $-82.13M | $45.92M | (m) | (m) | -1.79× | Reported |
| 2025-09-30 | (m) | (m) | $75.85M | $-97.13M | $40.18M | (m) | (m) | -2.42× | Reported |
| 2025-06-30 | (m) | (m) | $76.94M | $-114.90M | $33.87M | (m) | (m) | -3.39× | Reported |
| 2025-03-31 | (m) | (m) | $78.27M | $-137.12M | $27.38M | (m) | (m) | -5.01× | Reported |
| 2024-12-31 | (m) | (m) | $73.28M | $-136.17M | $24.88M | (m) | (m) | -5.47× | Reported |
| 2024-09-30 | (m) | (m) | $72.26M | $-157.18M | $22.14M | (m) | (m) | -7.10× | Reported |
| 2024-06-30 | (m) | (m) | $74.87M | $-161.84M | $20.03M | (m) | (m) | -8.08× | Reported |
| 2024-03-31 | (m) | (m) | $82.10M | $-176.39M | $18.11M | (m) | (m) | -9.74× | Reported |
| 2023-12-31 | (m) | (m) | $81.24M | $-173.40M | $16.64M | (m) | (m) | -10.42× | Reported |
| 2023-09-30 | (m) | (m) | $70.82M | $-163.59M | $13.55M | (m) | (m) | -12.07× | Reported |
| 2023-06-30 | (m) | (m) | $61.83M | $-160.20M | $10.38M | (m) | (m) | -15.43× | Reported |
| 2023-03-31 | (m) | (m) | $46.83M | $-146.09M | $7.92M | (m) | (m) | -18.44× | Reported |
| 2022-12-31 | (m) | (m) | $40.56M | $-146.97M | $5.50M | (m) | (m) | -26.70× | Reported |
| 2022-09-30 | (m) | (m) | $40.19M | $-150.09M | $5.68M | (m) | (m) | -26.42× | Reported |
| 2022-06-30 | (m) | (m) | $39.87M | $-150.24M | $5.67M | (m) | (m) | -26.51× | Reported |
| 2022-03-31 | (m) | (m) | $42.16M | $-150.24M | $6.63M | (m) | (m) | -22.67× | Reported |
| 2021-12-31 | (m) | (m) | $36.45M | $-128.06M | $7.11M | (m) | (m) | -18.02× | Reported |
| 2021-09-30 | (m) | (m) | $31.70M | $-106.95M | $9.31M | (m) | (m) | -11.49× | Reported |
| 2021-06-30 | (m) | (m) | $25.49M | $-84.69M | $10.80M | (m) | (m) | -7.84× | Reported |
| 2021-03-31 | (m) | (m) | $18.57M | $-60.10M | $11.44M | (m) | (m) | -5.25× | Reported |
| 2020-12-31 | (m) | (m) | $17.66M | $-58.86M | $12.37M | (m) | (m) | -4.76× | Reported |
| 2020-09-30 | (m) | (m) | $16.08M | $-56.33M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $15.14M | $-55.06M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $12.91M | $-54.32M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $10.96M | $-47.28M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | (m) | $9.43M | $-40.47M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | $7.50M | $-36.41M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | $6.30M | $-32.54M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | $5.30M | $-22.44M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $92.63M | $5.67M | $-18.35M | (m) | (m) | 6.13% | (m) | (m) |
| 2018-06-30 | (m) | $92.73M | $4.45M | $-12.08M | (m) | (m) | 4.80% | (m) | (m) |
| 2018-03-31 | (m) | $95.07M | $3.71M | $-6.27M | (m) | (m) | 3.91% | (m) | (m) |
| 2017-12-31 | (m) | $101.74M | $3.90M | $-9.00M | (m) | (m) | 3.84% | (m) | (m) |
| 2017-09-30 | (m) | $102.55M | $1.78M | $-12.46M | (m) | (m) | 1.74% | (m) | (m) |
| 2017-06-30 | (m) | $106.16M | $2.22M | $-15.75M | (m) | (m) | 2.09% | (m) | (m) |
| 2017-03-31 | (m) | $114.02M | $2.08M | $-15.33M | (m) | (m) | 1.83% | (m) | (m) |
| 2016-12-31 | (m) | $120.25M | $1.63M | $-15.38M | $5.37M | (m) | 1.35% | -2.86× | Reported |
| 2016-09-30 | (m) | $178.84M | $1.71M | $-10.41M | (m) | (m) | 0.96% | (m) | (m) |
| 2016-06-30 | (m) | $178.55M | $488.00K | $-175.66M | $13.26M | (m) | 0.27% | -13.25× | Reported |
| 2016-03-31 | (m) | $181.39M | $1.45M | $-177.32M | $12.57M | (m) | 0.80% | -14.10× | Reported |
| 2015-12-31 | $17.77M | $185.28M | $2.64M | $-172.44M | $12.59M | 9.59% | 1.43% | -13.70× | Reported |
| 2015-09-30 | (m) | $191.90M | $3.35M | $-163.66M | $13.83M | (m) | 1.75% | -11.84× | Reported |
| 2015-06-30 | (m) | $199.92M | $4.93M | $3.02M | $14.59M | (m) | 2.47% | 0.21× | Reported |
| 2015-03-31 | (m) | $206.45M | $4.86M | $7.69M | $15.30M | (m) | 2.36% | 0.50× | Reported |
| 2014-12-31 | $16.80M | $206.98M | $4.55M | $1.84M | $13.62M | 8.12% | 2.20% | 0.14× | Reported |
| 2014-09-30 | (m) | $206.42M | $4.89M | $-57.13M | $10.60M | (m) | 2.37% | -5.39× | Reported |
| 2014-06-30 | $15.56M | $205.60M | $4.24M | $-72.04M | $7.77M | 7.57% | 2.06% | -9.27× | Reported |
| 2014-03-31 | $14.69M | $203.45M | $3.84M | $-76.78M | $4.95M | 7.22% | 1.89% | -15.50× | Reported |
| 2013-12-31 | $14.19M | $204.72M | $4.08M | $-73.43M | $3.96M | 6.93% | 1.99% | -18.55× | Reported |
| 2013-09-30 | $14.26M | $204.40M | $4.31M | $-21.42M | $3.71M | 6.98% | 2.11% | -5.77× | Reported |
| 2013-06-30 | $14.45M | $201.04M | $4.46M | $-10.22M | $3.44M | 7.19% | 2.22% | -2.97× | Reported |
| 2013-03-31 | $14.56M | $198.26M | $4.33M | $-11.07M | $6.09M | 7.34% | 2.18% | -1.82× | Reported |
| 2012-12-31 | $14.89M | $196.28M | $3.69M | $-9.84M | $6.11M | 7.58% | 1.88% | -1.61× | Reported |
| 2012-09-30 | $14.24M | $193.04M | $2.71M | $-22.34M | $5.79M | 7.38% | 1.40% | -3.85× | Reported |
| 2012-06-30 | $14.88M | $193.82M | $2.19M | $-22.73M | $5.75M | 7.68% | 1.13% | -3.96× | Reported |
| 2012-03-31 | $15.48M | $196.45M | $2.26M | $-22.28M | $3.06M | 7.88% | 1.15% | -7.29× | Reported |
| 2011-12-31 | $16.89M | $197.71M | $2.42M | $-24.52M | $3.03M | 8.54% | 1.23% | -8.10× | Reported |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $16.43M | $171.61M | $3.18M | $-11.79M | $5.95M | 9.57% | 1.85% | -1.98× | Reported |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $13.49M | $120.62M | $3.57M | $-10.19M | $3.45M | 11.18% | 2.96% | -2.95× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |